0422 Cognitive Behavioral Therapy for Insomnia: The First Line Treatment for Insomnia Remains Elusive
Veronica Floyd,Cameron Turney,Arash Assar,Harrison Dickens,Mara Egeler,Jamie Walker,Ivan Vargas
DOI: https://doi.org/10.1093/sleep/zsae067.0422
IF: 6.313
2024-04-20
SLEEP
Abstract:Abstract Introduction Cognitive Behavioral Therapy for Insomnia (CBT-I) is a highly efficacious behavioral intervention for insomnia. However, no one has quantified to what extent United States citizens are familiar with or have used CBT-I (compared to other treatments like medication). This descriptive analyses study assessed the proportion of Americans that were familiar with and have used forms of sleep intervention, including CBT-I. Methods 3,082 participants across the United States were surveyed through Cloudresearch Connect. The mean age was 39.6 (Range = 18-85). The sample comprised of 48.7% women and 71.3% identified as White. Participants were asked (on a 7 point Likert scale) questions about sleep health. Participants were asked about their familiarity with insomnia treatments including: prescription and over-the-counter (OTC) medications, Melatonin, CBTI, Sleep Hygiene, Sleep Restriction Therapy (SRT), Stimulus Control Therapy (SCT), Relaxation or Mindfulness Meditation Therapy, and Light Therapy. Participants were asked if they had used any treatments prior to or within the past 12 months. Participants also completed the Insomnia Severity Index (ISI). Results Participants rated the importance of sleep on their physical (M = 6.2; SD = 0.99) and mental (M = 6.4; SD = 0.96) health. 52.7% of the participants had at least subthreshold insomnia (ISI score < 8). 17.7% had clinically elevated insomnia (ISI score > 15). As for familiarity with various sleep treatments, 65.5% recognized prescription medications (e.g., Ambien), 69.3% recognized OTC medications (e.g., antihistamines), 80.5% recognized melatonin, 15.1% recognized CBT-I, 26% recognized sleep hygiene, 4.4% recognized SRT, 5% recognized SCT, 47% recognized Relaxation or Mindfulness Meditation Therapy, and 26.4% recognized Light Therapy. Among participants with at least subthreshold levels of insomnia, only 3.6% used CBT-I in the past 12 months, and 5% had used it at least once. In the past 12 months, 49.2% had used OTC medication and 13.8% had used prescription medications. Conclusion The data shows that CBT-I remains under-utilized. The majority of participants only knew of medication (prescription and OTC) treatments for insomnia. Efforts to identify and address the barriers to increasing awareness and availability of CBT-I are important and could help struggling insomniacs compared to other methods previously attempted. Support (if any)
neurosciences,clinical neurology